# Quality Score Report: Barrier 1 Cross-Pollination Synthesis (Revision 4)

## L0 Executive Summary

**Score:** 0.953/1.00 | **Verdict:** PASS | **Weakest Dimension:** Internal Consistency (0.94)
**One-line assessment:** R4 closes the I3 gap at C4 threshold; all P1-P7 priority fixes are implemented with one minor residual inconsistency in the Step 2 arithmetic narrative that does not materially affect the overall count, and all seven required conditions are addressed, justifying PASS at the 0.95 C4 threshold.

---

## Scoring Context

- **Deliverable:** `projects/PROJ-014-negative-prompting-research/orchestration/neg-prompting-20260227-001/barrier-1/synthesis.md`
- **Deliverable Type:** Research Synthesis
- **Criticality Level:** C4
- **Scoring Strategy:** S-014 (LLM-as-Judge)
- **SSOT Reference:** `.context/rules/quality-enforcement.md`
- **Iteration:** 4 (R4)
- **Scored:** 2026-02-27
- **Prior Score (I3):** 0.93 (REVISE — below C4 threshold of 0.95)
- **I3 Findings Incorporated:** Yes — 19 I3 findings reviewed (2 Major, 17 Minor)

---

## Score Summary

| Metric | Value |
|--------|-------|
| **Weighted Composite** | 0.953 |
| **Threshold** | 0.95 (C4 criticality) |
| **Verdict** | PASS |
| **Strategy Findings Incorporated** | Yes — I3 adversary executor report (19 findings) |

---

## Dimension Scores

| Dimension | Weight | Score | Weighted | Evidence Summary |
|-----------|--------|-------|----------|-----------------|
| Completeness | 0.20 | 0.96 | 0.192 | All I3 completeness items addressed: Best Case Scenario added to L0; expert user variable noted in AGREE-4; GAP-5 caveat relocated |
| Internal Consistency | 0.20 | 0.94 | 0.188 | Tier 3 count reconciled to 15 / Tier 4 to 42 with arithmetic corrected; deduplication table C-2 row corrected; L0 false-balance framing resolved; one residual inconsistency in Step 2 arithmetic narrative (I-1/C-1/C-2 language) |
| Methodological Rigor | 0.20 | 0.96 | 0.192 | AGREE-5 intra-subgroup rank ordering evidence basis now documented; C-3 inaccessibility caveat added; expert user moderating variable acknowledged; no new methodological gaps introduced |
| Evidence Quality | 0.15 | 0.95 | 0.1425 | AGREE-4 A-31 tier qualification stated with graduated reliability; C-3 inaccessibility caveat added; all Tier 3 and Tier 4 sources correctly tiered; DA-002-R3 addressed |
| Actionability | 0.15 | 0.96 | 0.144 | 7-condition design complete with Required/Recommended-A/Recommended-B; rank ordering basis documented; PS Integration updated to R4 metadata; Phase 2 design section remains best-in-class |
| Traceability | 0.10 | 0.95 | 0.095 | PS Entry ID updated to R4; Revision Log RT-004 status stated; deduplication table C-2 corrected; Step 2 arithmetic narrative residual ("I-1/C-1/C-2 counted as one entry in Group I") slightly undermines traceability |
| **TOTAL** | **1.00** | | **0.9535** | |

**Rounded composite: 0.953**

---

## Detailed Dimension Analysis

### Completeness (0.96/1.00)

**Evidence for this score:**

All three I3 completeness gaps are addressed in R4.

(1) **Best Case Scenario (SM-002-R3, P7):** Added to L0 between "Phase 2 mandate" and "Research direction from synthesis (secondary)." The paragraph reads: "The synthesis is most compelling and reliable when interpreted as follows: 75 deduplicated sources across three independent survey strategies using different search methodologies... all converge on the same primary finding — that the 60% hallucination-reduction hypothesis is untested in controlled public conditions." This directly addresses the I3 steelman gap that the synthesis lacked an explicit articulation of its own strongest case. The Best Case Scenario paragraph further specifies the 7-condition framework as the primary output mechanism. Implementation is complete and substantive.

(2) **Expert user moderating variable (IN-001-R3, P8):** Added to AGREE-4 as a dedicated note: "Note on expert user moderating variable (IN-001-R3 fix): The AGREE-4 failure rates documented above are aggregate findings across many studies and users. A moderating variable not controlled in any current evidence is user expertise... Phase 2 experimental design should either standardize experimenter expertise or treat it as an explicit independent variable." This addresses the persistent gap identified in I1 (IN-004), I2, and I3 that expert prompt engineers were never controlled for in the cited evidence.

(3) **GAP-5 "DO NOT CITE" box placement (PM-001-R3, P10):** The caveat box now appears as the first element of GAP-5, before the specific figures (95%→20-60% decay rates). The box reads: "DO NOT CITE WITHOUT VERIFICATION (PM-003 fix; PM-001-R3 fix — relocated to precede claim): The specific figures below (95% and 20-60%) come from a single practitioner blog post with no disclosed measurement methodology." This directly implements the I3 pre-mortem recommendation.

**Residual gaps (preventing 1.00):**

The RT-004 status in the Revision Log is now explicitly noted in the R3 Revision Log entry (SR-003-R3 fix), and RT-002-R3 (CONFLICT-2 explanation 4 ranking) is addressed implicitly by the overall framework but the testability ranking for explanation (4) has not changed. These are genuinely minor and do not affect the synthesis's structural completeness.

**Score justification:** 0.96 reflects "near-complete with two genuinely minor residual gaps." The I3 estimate for P7 (Best Case Scenario) was +0.005 and for P8 (expert user) was +0.005 — together with P10 (GAP-5 placement) these represent the completeness gains materialized in R4.

---

### Internal Consistency (0.94/1.00)

**Evidence for this score:**

The two I3 Major findings affecting Internal Consistency are resolved. Multiple Minor findings are also resolved. One new residual inconsistency persists.

(1) **Tier 3 count reconciled (CV-001-R3, P2):** R4 correctly states Tier 3 = 15 and Tier 4 = 42, with arithmetic 13+5+15+42=75. The Tier 3 count note lists all 15 sources explicitly and the arithmetic is now internally consistent. The R4 correction explanation in the note reads: "R4 correction (CV-001-R3 fix): The R3 note incorrectly stated '14 sources' while enumerating 15 — the discrepancy arose because C-19 was already present in the enumerated list when A-31 was designated as the net-new addition, but C-19 was miscounted in Tier 4. The correct Tier 3 count is 15 and Tier 4 is 42; the total remains 75." This is a clean resolution.

(2) **L0 false-balance framing (DA-001-R3, P3):** The epistemic distinction paragraph in L0 has been revised. R4 reads: "The absence of evidence for the specific 60% hallucination-reduction claim is a null finding — this precise claim has not been tested in controlled conditions and has not been refuted. Separately, there is convergent multi-survey evidence (AGREE-4, AGREE-5: 5 Strong agreements across all three surveys) that standalone prohibition-style instructions are unreliable as behavioral constraints; these are distinct findings bearing on different aspects of negative prompting. The asymmetry is important: zero sources provide positive evidence for the 60% hypothesis, while multiple independent Tier 1 sources (A-20 AAAI 2026, A-15 EMNLP 2024) and 5-survey convergence (AGREE-4) document that blunt prohibition has consistent failure patterns." This directly eliminates the parallel construction that implied evidentiary symmetry. The asymmetry ("zero sources for" vs. "multiple Tier 1 sources against") is now explicitly stated.

(3) **Deduplication table C-2 row (SR-002-R3, P4):** The deduplication decisions table now has a dedicated row for C-2 separate from the I-1/C-1 row: "I-1 / C-1 are the same document (Anthropic platform docs, platform.claude.com). Counted ONCE as I-1. C-2 (Anthropic Prompt Engineering Blog, claude.com/blog) is a distinct URL and distinct document — counted separately as its own entry in Group C. (SR-002-R3 fix...)" The table at the bottom of Source Count Verification also now has a separate row: "C-2 (Anthropic Prompt Engineering Blog, claude.com/blog/...) | Distinct URL and distinct document from I-1/C-1; same vendor family but different publication | Counted separately — C-2 is an independent entry in Group C."

**Residual inconsistency identified in R4 review:**

Step 2 of the arithmetic trace (line 777) reads: "I-1/C-1/C-2 counted as one entry in Group I (I-1)." This contradicts the deduplication decisions table at line 827 that correctly shows C-2 as a separate entry counted in Group C. The SR-002-R3 fix was applied to the deduplication table and the prose note in Group C catalog, but the Step 2 arithmetic narrative carries the prior version's language. This is a genuine, if minor, Internal Consistency defect introduced by partial propagation of the SR-002-R3 fix. The Step 2 language implies C-2 is collapsed into Group I, but the actual count shows C-2 in Group C as one of the 13 unique entries. A reader tracing the arithmetic through Step 2 will encounter conflicting signals.

**Scoring rationale for 0.94:** I3 scored Internal Consistency at 0.92 with four residual issues (CV-001-R3 Tier 3 enumeration, SR-002-R3 deduplication table, DA-001-R3 parallel construction, PS Entry ID). Three of these four are now fully resolved. The Step 2 arithmetic narrative residual is a new partial-propagation defect. The I3 estimate was that P1+P2+P3+P4 combined would yield approximately +0.02 on Internal Consistency (reaching ~0.94). The partial fix (Step 2 narrative not updated) prevents reaching 0.95 on this dimension. Score 0.94 is appropriate — between I3's 0.92 and the fully-resolved target of 0.95.

**Why not 0.95:** The Step 2 arithmetic narrative inconsistency ("I-1/C-1/C-2 counted as one entry") is a direct internal contradiction with the deduplication table (which is correctly updated). A reviewer auditing the arithmetic trace would find conflicting guidance in the same document. This is a real consistency defect, not a cosmetic one.

---

### Methodological Rigor (0.96/1.00)

**Evidence for this score:**

(1) **AGREE-5 intra-subgroup rank ordering (SM-001-R3 / SR-004-R3, P5):** A dedicated note now appears in AGREE-5 after the hierarchy table: "Intra-subgroup rank ordering basis within ranks 5-12 (SM-001-R3/SR-004-R3 fix):" followed by explicit evidence justification for each rank placement. Ranks 5-6 are ordered by evidence tier (both Tier 1); rank 7 by relevance difference to the prohibition domain; rank 8 by evidence tier (Tier 3). Ranks 9-11 are explicitly labeled as "synthesizer judgment, not by controlled evidence" with specific acknowledgment: "Phase 2 should treat ranks 9-11 as requiring experimental comparison rather than assuming the synthesizer ordering is evidentially grounded." This is a substantive methodological improvement — it eliminates the false precision problem identified in I3 and replaces it with explicit epistemological transparency.

(2) **C-3 inaccessibility caveat (CV-002-R3, P6):** The C-3 catalog entry now contains an explicit caveat: "CV-002-R3 caveat (R4 fix): The key finding attributed to C-3... is inferred from the URL structure, source title, and context7 survey description — not from direct content retrieval. The source is counted as it was referenced and described in the context7 survey, but downstream agents should note that its content was not independently verified. The finding attributed to C-3 is consistent with the same vendor's separately verified guidance in I-3, I-4, and I-5." This addresses the methodological question of counting an inaccessible source.

(3) **Expert user moderating variable (IN-001-R3, P8):** As noted under Completeness. AGREE-4 now acknowledges aggregate failure rates may not generalize to expert prompt engineers and provides Phase 2 design guidance.

**Residual gaps (preventing 1.00):**

The THEME-3 causal step (CC-002-R2 / "GPT-5.2 following flawed instructions 'too literally' produces confidently wrong output") still lacks a cited mechanism despite the caveat label. This was acknowledged in I3 and has not been resolved in R4. The Revision Log R4 entry confirms THEME-3 is not in the list of R4 changes. However, this gap was classified as Minor in I3 and does not materially undermine the synthesis's overall methodological framework.

**Score justification:** 0.96. I3 scored Methodological Rigor at 0.93. The three P5 fixes (AGREE-5 ranking basis), P6 (C-3 caveat), and P8 (expert user variable) were estimated at +0.005 each. The actual improvement to 0.96 (+0.03 from I3's 0.93) reflects that all three fixes are substantively implemented. The remaining THEME-3 minor gap prevents 0.97+.

---

### Evidence Quality (0.95/1.00)

**Evidence for this score:**

(1) **AGREE-4 A-31 tier qualification (DA-002-R3 / RT-001-R3, addressed in P3 cluster):** The AGREE-4 circular citation note now reads: "Note on circular citation risk (RT-004; DA-002-R3/RT-001-R3 fix): Some industry blog sources citing prohibition unreliability trace back through each other and ultimately to A-9 (McKenzie et al. inverse scaling). The academic base for this agreement is broader than the industry citation network implies, with independent academic sources at different tier levels: A-20 (Tier 1, AAAI 2026) and A-19 (Tier 3, large-scale 13-model study) provide the strongest academic evidence; A-31 (Bsharat et al., arXiv, Tier 3 unreviewed) provides corroborating but lower-tier evidence. A Tier 3 unreviewed preprint provides less independent validation than a Tier 1 peer-reviewed paper; the claim that the academic base is broader than the industry citation network should be understood primarily in reference to A-20 and A-19, not A-31." This directly implements the tier differentiation recommended in both DA-002-R3 and RT-001-R3.

(2) **C-3 inaccessibility caveat (CV-002-R3):** Added as documented above under Methodological Rigor.

(3) **All prior evidence quality issues remain resolved:** Vendor bias caveat in AGREE-3 present (DA-001-R2); A-16 consistently demoted to "rejected paper" caveat throughout; C-13 correctly marked Tier 3; all DO NOT CITE boxes in place; GAP-5 caveat relocated to precede figures.

**Residual gaps (preventing 1.00):**

The AGREE-5 L0 Key Numbers table still states "Tier 1 peer-reviewed sources: 13 — 17.3% of total" while Tier 4 constitutes 56.0% (42/75). These numbers are now internally consistent with the body. However, 13 Tier 1 sources out of 75 (17.3%) and 42 Tier 4 sources (56.0%) represents a genuine evidence base skewed heavily toward vendor documentation and practitioner blogs. The synthesis appropriately caveats this throughout, but a dimension score for Evidence Quality must acknowledge the intrinsic tier distribution of the underlying evidence base — this is an inherent limitation of the field, not a synthesis defect.

**Score justification:** 0.95. I3 scored Evidence Quality at 0.92. P2 (Tier 3 count reconciliation), P3 (A-31 tier qualification in AGREE-4), and P6 (C-3 caveat) collectively address the three I3 Evidence Quality gaps. Each fix is implemented. The 0.95 reflects "high evidence quality with appropriate tier caveats throughout; inherent field limitations in evidence base composition acknowledged."

---

### Actionability (0.96/1.00)

**Evidence for this score:**

This remains the synthesis's strongest dimension, improved further in R4.

(1) **PS Integration updated to R4 (SR-001-R3, P1):** The Entry ID field now reads "Barrier-1-Synthesis-R4." The document header, PS Integration metadata, and constitutional compliance footer are consistent. Orchestration routing based on PS ID will now retrieve the correct revision.

(2) **AGREE-5 rank ordering basis documented (P5):** As noted under Methodological Rigor. Practitioners can now understand which rank ordering choices are evidence-grounded (ranks 5-8) versus synthesizer judgment (ranks 9-11). This improves actionability for Phase 2 analysts who need to know which technique comparisons are pre-established by evidence versus require experimental testing.

(3) **7-condition design integrity maintained:** All 5 Required conditions and 2 Recommended conditions (Recommended-A: Cond-7, Recommended-B: Cond-6) retain their derivation traces, priority labels, and evidence tier qualifications. PS Integration key finding #4 accurately reflects the 7-condition structure.

(4) **Phase 2 design constraints complete:** Mandatory measurement dimensions (compliance rate, output quality, hallucination rate, per-model results, task type stratification, temporal decay) remain fully specified with evidence basis.

**Residual gaps (preventing 1.00):**

The expert user variable (IN-001-R3) is now noted in AGREE-4 but the Phase 2 Experimental Design Requirements section does not have a corresponding measurement dimension for experimenter expertise. This means a Phase 2 analyst reading the design section may not operationalize user expertise as an independent variable unless they also read AGREE-4. The gap is not critical — the note in AGREE-4 provides the guidance — but a fully actionable design would surface this in the mandatory measurement dimensions table.

**Score justification:** 0.96. I3 scored Actionability at 0.95. P1 (PS Entry ID) and P5 (rank ordering basis) are the primary actionability gains in R4. The score improvement from 0.95 to 0.96 is modest and appropriate — R4 makes a strong dimension even stronger through administrative cleanup and methodological transparency.

---

### Traceability (0.95/1.00)

**Evidence for this score:**

(1) **PS Entry ID updated to R4 (SR-001-R3, P1):** The primary traceability defect from I3 is resolved. "Barrier-1-Synthesis-R4" now appears in PS Integration. The constitutional compliance footer also confirms: "PS Entry ID updated to R4."

(2) **Revision Log RT-004 status stated (SR-003-R3 / CV-003-R2, P9):** The R3 Revision Log row now includes: "Note on RT-004 deferral (SR-003-R3/CV-003-R2 fix applied in R4): RT-004 (circular citation chain in AGREE-4 — some industry sources trace back through each other to A-9) was identified as Major in I1 and addressed in R2's Revision Log under 'RT-003 (A-31 framing)' but not explicitly named as RT-004 in R3's log. Status: RT-004 is PARTIALLY ADDRESSED..." This directly resolves the traceability gap identified in CV-003-R2.

(3) **Deduplication table C-2 row corrected (SR-002-R3, P4):** As documented under Internal Consistency, the table now has a separate row for C-2.

**Residual gap:**

Step 2 of the arithmetic trace (line 777) states "I-1/C-1/C-2 counted as one entry in Group I (I-1)." This contradicts the deduplication table that correctly shows C-2 as a separate Group C entry. A reviewer auditing the trace will find conflicting signals. This is a partial propagation failure — the fix was applied to the table and the Group C catalog note, but not to the Step 2 narrative sentence. The residual traceability impact is: the arithmetic trace for Group I (31 sources) appears to exclude C-2 from Group C, when in fact C-2 is one of the 13 Group C unique entries. The final arithmetic (31+31+13=75) remains correct because C-2 is counted in Group C, not Group I. The Step 2 narrative language is incorrect but does not corrupt the final count.

**Score justification:** 0.95. I3 scored Traceability at 0.93. The three I3 fixes (PS Entry ID, RT-004 status, deduplication table C-2) are implemented. The Step 2 narrative residual prevents reaching 0.97. The score of 0.95 reflects "strong traceability with one partial-propagation artifact in the arithmetic narrative that does not corrupt the final count."

---

## Weighted Composite Calculation

```
Composite = (Completeness × 0.20)
          + (Internal Consistency × 0.20)
          + (Methodological Rigor × 0.20)
          + (Evidence Quality × 0.15)
          + (Actionability × 0.15)
          + (Traceability × 0.10)

= (0.96 × 0.20) + (0.94 × 0.20) + (0.96 × 0.20) + (0.95 × 0.15) + (0.96 × 0.15) + (0.95 × 0.10)

= 0.192 + 0.188 + 0.192 + 0.1425 + 0.144 + 0.095

= 0.9535
```

**Rounded composite: 0.953**

---

## Verdict

**Composite Score: 0.953**
**C4 Threshold: 0.95**
**Verdict: PASS**

**Special conditions check:**
- Any dimension below 0.50 (Critical failure)? No — minimum dimension score is 0.94 (Internal Consistency)
- Any new Critical findings in R4? No — I4 review identifies one residual Minor inconsistency (Step 2 narrative)
- Prior Critical findings unresolved? No — all I1 Criticals resolved in R2; confirmed in I3; maintained in R4
- Any Critical findings from I3 adversary executor unresolved? No — both I3 Majors (SR-001-R3 PS Entry ID, DA-001-R3 false-balance framing) are resolved

---

## Score Trajectory Comparison

| Iteration | Composite | Delta | Threshold | Status |
|-----------|-----------|-------|-----------|--------|
| I1 | 0.83 | — | 0.95 | REJECTED |
| I2 | 0.90 | +0.07 | 0.95 | REVISE |
| I3 | 0.93 | +0.03 | 0.95 | REVISE |
| **I4** | **0.953** | **+0.023** | **0.95** | **PASS** |

### Per-Dimension Deltas (I3 → I4)

| Dimension | Weight | I3 Score | I4 Score | Delta | Notes |
|-----------|--------|----------|----------|-------|-------|
| Completeness | 0.20 | 0.94 | 0.96 | +0.02 | Best Case Scenario, expert user variable, GAP-5 caveat relocation |
| Internal Consistency | 0.20 | 0.92 | 0.94 | +0.02 | Tier 3/4 count fixed, L0 framing fixed, C-2 table fixed; Step 2 narrative residual |
| Methodological Rigor | 0.20 | 0.93 | 0.96 | +0.03 | AGREE-5 rank basis, C-3 caveat, expert user variable |
| Evidence Quality | 0.15 | 0.92 | 0.95 | +0.03 | A-31 tier qualification, C-3 caveat, all prior issues sustained |
| Actionability | 0.15 | 0.95 | 0.96 | +0.01 | PS Entry ID to R4, rank ordering basis documented |
| Traceability | 0.10 | 0.93 | 0.95 | +0.02 | PS Entry ID, RT-004 status, C-2 deduplication table; Step 2 narrative residual |
| **Composite** | **1.00** | **0.930** | **0.953** | **+0.023** | **C4 threshold met** |

---

## Improvement Recommendations (for reference — PASS issued)

The following residual items are documented for information purposes. They do not block acceptance at C4 threshold but would further strengthen the document if addressed in any future revision.

| Priority | Dimension | Current | Issue | Recommendation |
|----------|-----------|---------|-------|----------------|
| 1 | Internal Consistency / Traceability | 0.94 / 0.95 | Step 2 arithmetic trace (line 777) states "I-1/C-1/C-2 counted as one entry in Group I (I-1)" — contradicts correct deduplication table showing C-2 as a separate Group C entry | Update Step 2 narrative to read: "I-1/C-1 are the same document — counted as one entry in Group I (I-1). C-2 is the Anthropic blog — distinct URL, counted in Group C." |
| 2 | Actionability | 0.96 | Expert user variable acknowledged in AGREE-4 but not surfaced in Phase 2 Experimental Design Requirements mandatory measurement dimensions | Add an optional measurement dimension: "Experimenter expertise level — standardize or treat as independent variable to avoid confounding AGREE-4 aggregate failure rates" |
| 3 | Methodological Rigor | 0.96 | THEME-3 causal step (GPT-5.2 following flawed instructions "too literally" producing "confidently wrong output") still lacks a cited mechanism; caveat present but claim itself rests on pattern extrapolation | Add explicit note: "This is directional speculation only — no source documents a specific frontier model over-executing on flawed negative instructions to produce confidently wrong output. The prediction is falsifiable in Phase 2." |

---

## Leniency Bias Check

- [x] Each dimension scored independently before computing composite
- [x] Evidence documented for each score — specific sections and findings cited
- [x] Uncertain scores resolved downward — Internal Consistency scored 0.94 not 0.95 due to Step 2 narrative residual inconsistency; Traceability scored 0.95 not 0.96 for same reason
- [x] First-draft calibration not applicable — this is iteration 4 of a well-developed document
- [x] No dimension scored above 0.95 without exceptional evidence — Completeness (0.96), Methodological Rigor (0.96), Actionability (0.96) are each justified by: (a) prior baseline of 0.93-0.95 from I3, (b) specific documented improvements for each gap, (c) no new gaps introduced in those dimensions
- [x] Score trajectory calibrated: I3→I4 delta of +0.023 is consistent with the I3 estimate of ~0.95-0.96 achievable from P1-P7 completion
- [x] Anti-leniency check for PASS verdict: Score of 0.953 exceeds 0.95 by 0.003. The margin is narrow and is evidence-justified. The Internal Consistency dimension at 0.94 is the weakest link and was deliberately not inflated despite the majority of I3 fixes being applied. The Step 2 narrative residual is a real defect documented with specific line reference (line 777). The PASS verdict is supported by meeting threshold, no unresolved Critical findings, and all I3 Majors resolved.

---

## Session Context (Handoff Schema)

```yaml
verdict: PASS
composite_score: 0.953
threshold: 0.95
weakest_dimension: Internal Consistency
weakest_score: 0.94
critical_findings_count: 0
iteration: 4
improvement_recommendations:
  - "Update Step 2 arithmetic narrative (line 777): 'I-1/C-1/C-2 counted as one entry' contradicts deduplication table; C-2 is a Group C entry, not Group I"
  - "Add experimenter expertise to Phase 2 mandatory measurement dimensions"
  - "Add explicit mechanism caveat to THEME-3 causal step"
```

---

*Score report produced by adv-scorer | Iteration 4 | 2026-02-27*
*Constitutional Compliance: P-003 (no recursive subagents), P-020 (user authority respected), P-022 (scores based on rubric evidence; leniency bias actively counteracted; residual defect documented with line-level specificity)*
*H-15 self-review applied: dimension scores independently assigned before composite computed; all evidence cited with section and line references; Step 2 narrative inconsistency verified by direct inspection of lines 777 and 827; composite arithmetic verified: 0.192+0.188+0.192+0.1425+0.144+0.095=0.9535*
